
RTSN Market Capitalization Overview
Market Cap: $82.99M as of Oct 9, 2026
$82.99M
$0.00 (0.00%)past month
As of Oct 9, 2026, RTSN has a market capitalization of $82.99M. Over the past 30 days, its market cap has increased by —, while in the last 12 months, it has increased by —.
Market capitalization represents the total value of Retension Pharmaceuticals Inc. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RTSN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RTSN helps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Retension Pharmaceuticals Inc. as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
RTSN Market Cap Formula = Stock Price * Shares Outstanding
The market cap of RTSN helps investors assess the company's size and compare it with competitors for better investment decisions.
RTSN Market Cap & Key Trends
See Retension Pharmaceuticals Inc.’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in RTSN
Order type
Buy in
Order amount
Est. shares
0 shares
RTSN Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| Oct 9, 2026 | $82.99M | — |
RTSN End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $82.99M | — |
FAQs About Retension Pharmaceuticals Inc. (RTSN) Market Cap
As of Oct 9, 2026, the market capitalization of RTSN is $82.99M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Retension Pharmaceuticals Inc.’s market capitalization has increased by 0.0000%, changing from $82.99M to $82.99M as of Oct 9, 2026.
In the last 3 months, Retension Pharmaceuticals Inc.’s market capitalization has increased by —, changing from – to – as of –.
In the year –, Retension Pharmaceuticals Inc.’s market capitalization increased from – in January to – in December, reflecting a — change.